C6orf81 Inhibitors
The chemical class termed C6orf81 Inhibitors encompasses a diverse array of compounds targeting specific cellular pathways and processes. Y-27632 inhibits ROCK, impacting cytoskeletal dynamics and potentially influencing cellular processes linked to C6orf81. AG-490, a JAK2 inhibitor, disrupts the JAK-STAT signaling pathway, affecting downstream events related to C6orf81. AICAR, by activating AMPK, modulates cellular energy balance, potentially influencing pathways associated with the protein. SB-431542 inhibits the TGF-β type I receptor, disrupting TGF-β signaling and indirectly impacting cellular processes associated with C6orf81.
GDC-0941, a PI3K inhibitor, and Rapamycin, an mTOR inhibitor, disrupt the PI3K/Akt and mTOR signaling pathways, respectively, potentially affecting downstream events related to C6orf81. PD98059 inhibits MEK1, disrupting the MAPK/ERK pathway, while JSH-23 inhibits NF-κB activation, potentially impacting inflammatory responses and cellular processes related to C6orf81. BIX-01294, a histone methyltransferase inhibitor, modulates chromatin structure and gene expression, potentially influencing cellular processes associated with C6orf81. PI-103, a dual PI3K/mTOR inhibitor, disrupts both PI3K and mTOR signaling pathways, potentially affecting downstream events related to C6orf81. FR180204 inhibits ERK, disrupting the MAPK/ERK signaling pathway, and S3I-201 inhibits STAT3, disrupting the JAK-STAT signaling pathway. Together, these inhibitors form a class with diverse mechanisms, collectively influencing cellular processes associated with C6orf81.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits Rho-associated protein kinase (ROCK), impacting cytoskeletal dynamics. Inhibition of ROCK can potentially influence cellular processes linked to C6orf81. | ||||||
AG-490 | 133550-30-8 | sc-202046C sc-202046A sc-202046B sc-202046 | 5 mg 50 mg 25 mg 10 mg | $84.00 $329.00 $223.00 $87.00 | 35 | |
AG-490 is a Janus kinase 2 (JAK2) inhibitor. Inhibition of JAK2 can disrupt the JAK-STAT signaling pathway, potentially affecting cellular events associated with C6orf81. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMP-activated protein kinase (AMPK), modulating cellular energy balance. Activated AMPK can potentially influence pathways related to C6orf81. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 inhibits the TGF-β type I receptor, disrupting TGF-β signaling. Inhibition of this pathway may indirectly influence cellular processes associated with C6orf81. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $188.00 $199.00 | 2 | |
GDC-0941 is a phosphoinositide 3-kinase (PI3K) inhibitor, disrupting the PI3K/Akt signaling pathway. Inhibition of PI3K can potentially impact downstream events related to C6orf81. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mammalian target of rapamycin (mTOR), impacting the mTOR signaling pathway. Inhibition of mTOR can potentially influence cellular processes linked to C6orf81. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK1, an upstream regulator of ERK1/2. Inhibition of MEK1 disrupts the MAPK/ERK pathway, potentially affecting cellular events associated with C6orf81. | ||||||
NFκB Activation Inhibitor II, JSH-23 | 749886-87-1 | sc-222061 sc-222061C sc-222061A sc-222061B | 5 mg 10 mg 50 mg 100 mg | $214.00 $257.00 $1775.00 $2003.00 | 34 | |
JSH-23 inhibits nuclear factor-kappa B (NF-κB) activation. Inhibition of NF-κB may impact inflammatory responses and cellular processes related to C6orf81. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
BIX-01294 is a histone methyltransferase inhibitor, potentially altering chromatin structure and gene expression. Modulation of gene expression can impact cellular processes associated with C6orf81. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $33.00 $131.00 | 3 | |
PI-103 is a dual PI3K/mTOR inhibitor, disrupting both PI3K and mTOR signaling pathways. Inhibition of these pathways can potentially affect downstream events related to C6orf81. | ||||||